Xavi Anguela

Company: Estuary Biotherapeutics

Job title: Chief Scientific Officer

Seminars:

Build vs. Buy: Should You Develop a Functionality In-House or License it from Contemporaries 2:00 pm

The gene therapy industry is exploding with many new players entering the industry every year. As a result, companies are finding it increasingly difficult to navigate the IP space and make informed financial decision around building or licensing technologies. Learn from the experiences of key-opinion leaders in the space to de-risk these decisions earlier. This…Read more

day: Pre-Conference Day